Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.10 (6.25%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Acquisition

9 Sep 2019 07:00

RNS Number : 5818L
Iconic Labs PLC
09 September 2019
 

9 September 2019

Iconic Labs Plc ("Iconic Labs" or the "Company")

Acquisition

 

Iconic Labs Plc (LSE:ICON), a multi-divisional new media and technology business is pleased to announce that it has acquired the IP of Gay Star News Ltd ('GSN') including www.gaystarnews.com, a website focused on events related to and concerning the global LGBTI community. The acquisition is part of the Company's strategy to build critical mass and in particular expand its proprietary targeted distribution channels that the Company can utilise under the Iconic Labs brand offering. This transaction follows the announcement of the agreement to acquire Social Alchemist a social media focussed agency, which provides online media consultancy and content generation, and distribution through its established platforms which connect with over 12 million people.

 

GSN is currently in the top three of LGBTI publishers in the UK and focusses on creating content on news topics both within the LGBTI community and general news. It has a strong social presence on Facebook boasting c.800,000 followers, the support from a strong celebrity base and has pioneered campaigns and events which have had global exposure. Its platforms and content generation fit in with the Iconic Labs business model of developing content and distribution channels for targeted influential audiences.

 

The IP was acquired through the Company acquiring the entire issued share capital of Nuuco Media Ltd ('NCM') for £1. NCM, a company previously owned by David Sefton, a director of Iconic Labs, had acquired the IP from GSN following GSN going into a creditors voluntary liquidation. The reason for enacting the transaction in this manner was because the appointed liquidators insisted on concluding the transaction for the sale of GSN's IP in a very short timetable, for which NCM was able to fulfil. The outstanding consideration owed to the liquidator by NCM of £33,000 is payable by Iconic Labs with settlement being satisfied using funds previously allocated by the Board for small acquisitions such as this. Iconic Labs has not acquired any costs or liabilities associated with GSN, which reported unaudited revenues in FY 2018 of over £500,000.

 

The Board believe the acquisition of such a credible brand, with the proven capability to generate in excess of £500,000 a year in revenue for £33,000, represents exceptional value for Iconic Labs. Although the liquidation process does not allow the transferral of contracts and the associated derived revenues to the new purchaser, the Iconic Labs management is already actively reengaging historic clients and is confident in securing these relationship and the associated revenues in the future.

 

The Board believes that by utilising its experience and putting GSN under the Iconic Labs umbrella, it can maximise the opportunity and create a profitable centre for the Company. The Board plans to work on a rebrand and relaunch of GSN in the coming months and believes the business will be highly complementary to the agency and consulting offerings from the Iconic Labs group as a whole. Importantly the Board do not believe that significant working capital will be required to bring the relaunched GSN to profitability in a short time frame.

 

Chief Executive Officer, John Quinlan, said: "This is acquisition is a further step forward in building our platform for both the distribution and creation of online content. We believe we have the capabilities in house to leverage the strong position Gay Star News has in its targeted marketplace, build the business into the number one spot in terms of followers and make it a profitable business centre. It represents a strong fit for Iconic Labs and enables us to strengthen our market presence in the online media space and progress our business model." 

 

"GSN is one of the most credible and professional publishers for an LGBTI audience. We believe that strong editorial independence and high levels of engagement and interaction is very important to both the LGBTI community, brand and long term prospects of the business, and we are looking forward to working on making GSN a success.

 

"I remain fully committed to building a successful business and with economies of scale being achieved we believe we can both attract new corporates and people to the Iconic Labs family and reward shareholders for their patience." 

Business Development Officer, Liam Harrington, said, "Gay Star News is a fantastic platform which has a loyal and engaged following. It has a premium status within its targeted audience and I believe our team's expertise can increase engagement numbers and further build on the strong market presence already achieved."

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

John Quinlan

Iconic Labs Plc

c/o SBP Tel: +44 (0) 20 7236 1177

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Erik Woolgar

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Melissa Hancock

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

Juliet Earl

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQBCGDCRSGBGCI
Date   Source Headline
30th Oct 20184:25 pmRNSNotice of AGM
30th Oct 20182:05 pmRNSSecond Price Monitoring Extn
30th Oct 20182:00 pmRNSPrice Monitoring Extension
30th Oct 20187:00 amRNSWideacademy Restructuring
29th Oct 20184:33 pmRNSHolding(s) in Company
23rd Oct 20188:27 amRNSConversion of Bond
22nd Oct 20183:27 pmRNSConversion of bonds
22nd Oct 20187:00 amRNSSmart Cells Deal
19th Oct 20189:20 amRNSHolding(s) in Company
18th Oct 201812:47 pmRNSBoard Restructuring
17th Oct 20184:48 pmRNSHolding(s) in Company
1st Oct 201811:00 amRNSPrice Monitoring Extension
28th Sep 20183:30 pmRNSHolding(s) in Company
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 201810:40 amRNSNotification of transactions of Directors
27th Sep 20187:10 amRNSInterim Results
27th Sep 20187:00 amRNSFinancing Agreement
30th Jul 20187:00 amRNSCellPlan Launch in Spain
9th Jul 20187:01 amRNSBoard Changes
9th Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20183:00 pmRNSResult of AGM
28th Jun 201810:30 amRNSResult of General Meeting
15th Jun 20187:00 amRNSAlign Research Initiation of Coverage
12th Jun 20186:25 pmRNSProspectus and Notice of General Meeting
11th Jun 20189:00 amRNSLive Market Bookbuild Closes
11th Jun 20187:30 amRNSRestoration Widecells Group Plc
11th Jun 20187:00 amRNSUpdate Regarding Placing and Financial Position
6th Jun 20183:00 pmRNSNotice of AGM
5th Jun 20187:00 amRNSAudited Preliminary Results
21st May 20187:00 amRNSFinal Results Update
10th May 201810:30 amRNSPlacing to Raise £1.47m and Live Market Bookbuild
3rd May 20187:30 amRNSSuspension Widecells Group
1st May 20187:02 amRNSAnnual Accounts and Fundraising Update
26th Mar 20187:00 amRNSLandmark deal to launch CellPlan insurance in Asia
19th Mar 20187:00 amRNSGranted Innovate UK KTP for Stem Cell Research
27th Feb 20187:00 amRNSLicence Award from the Human Tissue Authority
19th Feb 20187:00 amRNSBoard Changes and Launch of Wideacademy Platform
21st Dec 20177:00 amRNSCorporate Update
2nd Nov 20177:00 amRNSRevenue generation with White Apex agreement
12th Oct 20177:00 amRNSCellPlan expansion, e-commerce platform launch UK
11th Oct 20177:00 amRNSPartner Secured to Expand into MENA & Asia-Pacific
29th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSWideacademy Update, Presenting at Investor Event
15th Aug 20177:00 amRNSRaises £750,000 to support Company's divisions
31st Jul 20177:00 amRNSResearch Licence Granted from HTA
24th Jul 20177:00 amRNSNew product to target the dental market
21st Jul 20177:00 amRNSCellPlan launches E-Commerce Platform in the UK
12th Jul 20177:00 amRNSCorporate Charity Commitment
4th Jul 20177:00 amRNSAgreement to Roll Out CellPlan in Brazil

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.